Ironwood Pharmaceuticals | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Almirall EUR 1.49B 10.37M 2024-06
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amarin USD 531.38M 20.5M 2024-09
Ardelyx USD 173.29M 14.99M 2024-12
Astellas Pharma JPY 1.49T 36.03B 2024-12
AstraZeneca USD 40.87B 66M 2024-12
Charles River Laboratories USD 3.46B 320.77M 2024-12
Exact Sciences USD 2.4B 808.26M 2024-12
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Incyte USD 3.45B 276.41M 2024-12
Ironwood Pharmaceuticals USD -301245000 10.09M 2024-12
MacroGenics USD 120.07M 62.25M 2024-09
Moderna USD 10.9B 1.03B 2024-12
Myriad Genetics USD 701.1M 30.6M 2024-12
Pacira USD 778.35M 28.76M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Takeda JPY 7.42T 497.52B 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12



Ironwood Pharmaceuticals Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.